I was at my gastroenterologist last week. He passed on the following news adding that this is the first time (praticing over 30 years) that he has ever seen a risk being removed from guidelines.
In August of this year, the National Comprehensive Cancer Network (NCCN) guidelines removed the warning that a CHEK2 mutation increases the risk of colorectal cancer. The new guidelines recommend that if you have a CHEK2 mutation you should first consider your family history and other factors. The guidelines now recommend you follow the general population screening guidelines.
They further indicated … some studies have suggested that some CHEK2 variants may be associated with an increased risk of thyroid, pancreatic, kidney, and stomach cancers. However, such evidence is limited and more research is needed to make a determination regarding these associations before any recommendations for screening for these cancers can be recommended. There is insufficient evidence to suggest that CHEK2 pathogenic variants are associated with an increased risk for ovarian cancer at this time.